Multiprofile Hospital for Active Treatment Sveti Ivan Rilski - Razgrad AD
Razgrad 7200
0 studies enrolling now · 2 studies all time
What they study most
COVID-19
Studies at this site
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
— Completed
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
— Stopped early